A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort
Authors
Keywords
Genetic modifier, Gender effect, Neurodegeneration, Huntington disease
Journal
BMC Neurology
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-01-03
DOI
10.1186/1471-2377-14-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PGC-1 is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis
- (2013) J. Eschbach et al. HUMAN MOLECULAR GENETICS
- DNA Sequence Variants in PPARGC1A, a Gene Encoding a Coactivator of the ω-3 LCPUFA Sensing PPAR-RXR Transcription Complex, Are Associated with NV AMD and AMD-Associated Loci in Genes of Complement and VEGF Signaling Pathways
- (2013) John Paul SanGiovanni et al. PLoS One
- A PGC-1α Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophy
- (2012) Jorge L. Ruas et al. CELL
- The Role of PGC-1α in the Pathogenesis of Neurodegenerative Disorders
- (2012) Krisztina Rona-Voros et al. CURRENT DRUG TARGETS
- A greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset†
- (2012) Selma M. Soyal et al. HUMAN MOLECULAR GENETICS
- CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
- (2012) J.- M. Lee et al. NEUROLOGY
- PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease
- (2011) Elahe Taherzadeh-Fard et al. Molecular Neurodegeneration
- Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease
- (2011) Hong Van B Che et al. Molecular Neurodegeneration
- Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY
- (2010) M. Orth et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- The gene coding for PGC-1α modifies age at onset in Huntington's Disease
- (2009) Patrick Weydt et al. Molecular Neurodegeneration
- PGC-1alpha as modifier of onset age in Huntington disease
- (2009) Elahe Taherzadeh-Fard et al. Molecular Neurodegeneration
- Sex differences in molecular neuroscience: from fruit flies to humans
- (2009) Elena Jazin et al. NATURE REVIEWS NEUROSCIENCE
- The biology of PGC-1α and its therapeutic potential
- (2009) Christoph Handschin TRENDS IN PHARMACOLOGICAL SCIENCES
- Huntington's disease: the case for genetic modifiers
- (2009) James F Gusella et al. Genome Medicine
- Sex differences in a transgenic rat model of Huntington's disease: decreased 17β-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males
- (2008) Felix J. Bode et al. HUMAN MOLECULAR GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now